Dissiminated actinic keratoses. Comparison of therapies with topical, photodynamic 5-aminolevulinic acid and topical 5% imiquimod cream;Ausgedehnte aktinische keratosen. Vergleich einer topischen photodynamischen therapie mit 5-aminolävulinsäure und topischer 5%iger imiquimod-creme

Hautarzt

Volumn 52, Issue 10 II, 2001, Pages 942-946

  Cerburkovas, O ^a,b   Krause, M ^a   Ulrich, J ^a   Bonnekoh, B ^a   Gollnick, H ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b KAUNAS UNIVERSITY OF TECHNOLOGY   (Lithuania)

Author keywords

Actinic keratosis; Aminolevulinic acid; Imiquimod; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID; IMIQUIMOD;

ACTINIC KERATOSIS; AGED; ARTICLE; CASE REPORT; DRUG EFFICACY; FEMALE; FOLLOW UP; FOREARM; HUMAN; PHOTODYNAMIC THERAPY; SUN EXPOSURE; TREATMENT OUTCOME;

EID: 0034783375     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050170003     Document Type: Article

References (20)

1. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
2. Utility of step sections: Demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis
3. The treatment of actinic keratosis
4. Green light is effective and less painful than red light in photodynamic therapy of facial solar keratosis
5. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three weekly or once per day
6. Retinoids
7. Solar keratosis: An evolving squamous cell carcinoma. Benign or malignant?
8. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid
9. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinoma in a basal cell nevus syndrome patient
10. Photodynamic therapy in dermatology
11. Toward the biologic treatment of nonmelanoma skin cancer
12. Malignant transformation of solar keratoses to squamous cell carcinoma
13. Imiquimod applied topically: A novel immune response modifier and new class of drug
14. Premalignant keratinocytic neoplasms
15. Mechanismus of action of imiquimod
16. A possible new incoherent lamp for photodynamic treatment of superficial skin lesions
17. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: An initial clinical study
18. Penetration potency of topical applied δ-aminolevulic acid for photodynamic therapy of basal cell carcinoma
19. Phase I trial of an oral immunomodulator and interferon inducer in cancer patients